Author:
Boyce S.,Rupniak N.M.J.,Steventon M.,Iversen S. D.
Abstract
Systemic administration of CCK-8S (1 or 10 μg/kg IP) markedly inhibited l-dopa-induced dyskinesias in parkinsonian monkeys, but did not interfere with locomotor stimulation by l-dopa. CCK analogues may be useful antidyskinetic agents for improved control of Parkinson's disease.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献